NCT07518680

Brief Summary

This study is a single-center, self-controlled trial. Patients will successively undergo voluntary coughing without intervention, a washout period, coughing stimulated by pressing the Tiantu acupoint, a washout period, and voluntary coughing without intervention. Vital signs of the patients before and after each cough will be recorded, as well as the changes in peak cough flow rate and intra-abdominal pressure after each cough. For peak cough flow rate and intra-abdominal pressure, three sets of data will be collected each time, and the best value will be taken. This pilot trial is conducted to verify the feasibility of the research design and to provide sample size estimation and data support for the main study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 10, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2026

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Completed
Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

1 month

First QC Date

January 29, 2026

Last Update Submit

April 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cough peak expiratory flow rate at each time point

    The maximum expiratory flow rate generated in the airway when coughing forcefully and rapidly. Measured by a portable peak flow meter sealed at the patient's mouth during coughing. It is a crucial and objective quantitative indicator for evaluating cough efficiency and the strength of the expiratory muscles.

    Baseline, during acupoint stimulation, and 30 minutes post-stimulation

Secondary Outcomes (4)

  • Change in intra-abdominal pressure at each time point

    Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  • Oxygen saturation at each time point

    Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  • Blood pressure at each time point

    Baseline, during acupoint stimulation, and 30 minutes post-stimulation

  • Heart rate at each time point

    Baseline, during acupoint stimulation, and 30 minutes post-stimulation

Study Arms (1)

Pressing the Tiantu acupoint to stimulate coughing

EXPERIMENTAL

At the end of the patient's inhalation, trained and qualified personnel with qualifications perform the compression. The right thumb or middle and index fingers are flexed and use the tips of the fingers to press on the patient's thyroid cartilage point (the thyroid cartilage point is located on the anterior midline of the neck, in the center of the supra-sternal fossa). Press vertically inward, with the tips of the fingers touching each other closely, aiming to cause itching in the throat. Stimulate the trachea to trigger a cough. The force should be at the minimum level that can produce a cough reflex. The pressure of the fingers is measured using a pressure gauge, which is 1.59 to 3.45 N. Each compression lasts for 4 seconds, with an interval of 5 minutes. Repeat this process 3 times (select the best value).

Other: Pressing the Tiantu acupoint to stimulate coughing

Interventions

At the end of inhalation, press the Tiantu acupoint to stimulate coughing. The specific operation method has been mentioned earlier.

Pressing the Tiantu acupoint to stimulate coughing

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntarily sign the informed consent form and follow the requirements of the protocol;
  • Age 18 to 75 years old (inclusive), gender not limited;
  • Patients who have undergone esophageal surgery (without intubation);
  • Not taking psychotropic drugs, mentally sound, and likely to cooperate in completing the assessment and intervention.

You may not qualify if:

  • The subjects or their family members request to withdraw from the study;
  • Pregnancy or lactation period;
  • Severe heart and lung diseases (such as heart failure, acute exacerbation of COPD, asthma, etc.);
  • Skin damage or infection in the area of the Tiantu acupoint;
  • Within the last month, have received other cough-related interventions (such as acupuncture, physical therapy);
  • Other situations that the researcher deems unsuitable for participating in this clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Hospital

Shanghai, Shanghai Municipality, 200032, China

Location

MeSH Terms

Conditions

Esophageal Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Study Officials

  • Minjie Ju, ScD

    Shanghai Zhongshan Hospital

    STUDY DIRECTOR

Central Study Contacts

Minjie Ju, ScD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2026

First Posted

April 8, 2026

Study Start

April 10, 2026

Primary Completion

May 10, 2026

Study Completion

May 31, 2026

Last Updated

April 8, 2026

Record last verified: 2026-03

Locations